If a patient is taking prednisone, should the Tdap (tetanus, diphtheria, pertussis) vaccine be postponed until the prednisone course is completed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should Tdap Be Held in Patients on Prednisone?

Whether to hold Tdap depends entirely on the prednisone dose: give Tdap immediately if the patient is on ≤20 mg daily, but defer until the dose is tapered below 20 mg daily if they are on ≥20 mg daily.

Dose-Based Algorithm

The 2022 American College of Rheumatology guidelines provide clear, dose-stratified recommendations for non-live vaccines like Tdap in patients taking prednisone 1:

Prednisone ≤10 mg daily

  • Give Tdap now (strong recommendation)
  • No need to wait or adjust timing
  • Vaccine immunogenicity is preserved at this dose

Prednisone >10 mg but <20 mg daily

  • Give Tdap now (conditional recommendation)
  • While there may be some reduction in vaccine response, the benefit of timely vaccination outweighs waiting
  • Studies show higher doses reduce immunogenicity, but the effect is less pronounced in this range

Prednisone ≥20 mg daily

  • Defer Tdap until prednisone is tapered to <20 mg daily (conditional recommendation)
  • High-dose glucocorticoids (≥20 mg) significantly blunt vaccine responses 1
  • The exception is influenza vaccine, which should be given on schedule due to seasonal timing—but Tdap has no such urgency

Key Evidence and Rationale

The dose threshold of 20 mg daily is based on multiple studies demonstrating that prednisone ≥20 mg significantly impairs vaccine immunogenicity 1. The guidelines explicitly state that for non-influenza vaccines (which includes Tdap), deferring vaccination until glucocorticoid taper maximizes vaccine efficacy 1.

Research in IBD patients supports this approach: combined immunosuppression (including corticosteroids) impaired tetanus and pertussis antibody responses, with the lowest response rates in heavily immunosuppressed patients 2.

Important Caveats

When you cannot defer:

  • Children requiring vaccination for school entry should receive Tdap even on high-dose prednisone 1
  • Tetanus prophylaxis for wound management takes precedence—give Tdap if ≥5 years since last tetanus-containing vaccine, regardless of prednisone dose 3
  • Pregnancy: If the patient is in the third trimester, give Tdap to protect the infant from pertussis, as timing is critical 3, 4

Clinical considerations:

  • The goal of deferring is to maximize vaccine efficacy, not because of safety concerns—Tdap is safe to give at any prednisone dose 1
  • If the patient is unlikely to taper below 20 mg in a reasonable timeframe, consider giving Tdap anyway to provide at least partial immunity
  • Document the prednisone dose and timing decision in the medical record

Safety Note

Tdap is a non-live vaccine and poses no infection risk to immunosuppressed patients 3. The concern is purely about reduced antibody response and suboptimal protection, not adverse events from the vaccine itself.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.